Profil
Scott Jeffers is currently the Chief Technical Officer at Gensight Biologics SA since 2022.
Previously, he worked as the Director-Gene Therapy at Selecta Biosciences, Inc. and as the VP-CMC Process Development & Manufacturing at Redpin Therapeutics, Inc. Dr. Jeffers completed his undergraduate degree at Colorado State University and holds a doctorate from Purdue University.
Aktive Positionen von Scott Jeffers
| Unternehmen | Position | Beginn |
|---|---|---|
| GENSIGHT BIOLOGICS S.A. | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2022 |
Ehemalige bekannte Positionen von Scott Jeffers
| Unternehmen | Position | Ende |
|---|---|---|
| CARTESIAN THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Redpin Therapeutics, Inc.
Redpin Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnological platform which enables targeted regulation of neuronal activity in brain to achieve treatment and control of CNS circuit and other disorders | Corporate Officer/Principal | - |
Ausbildung von Scott Jeffers
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Selecta Biosciences, Inc.
Selecta Biosciences, Inc. BiotechnologyHealth Technology Develops targeted immunotherapies and vaccines to treat and prevent diseases | Health Technology |
Colorado State University
Colorado State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Purdue University
Purdue University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gensight Biologics SA
Gensight Biologics SA Pharmaceuticals: MajorHealth Technology Manufactures and markets novel therapies for severe retinal neurodegenerative diseases | Health Technology |
Redpin Therapeutics, Inc.
Redpin Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnological platform which enables targeted regulation of neuronal activity in brain to achieve treatment and control of CNS circuit and other disorders | Commercial Services |
















